Delivery Order SPE2DB20D2104-SPE2DB21FT70D
Award Date 8/17/21
Potential Completion Date 8/18/21
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The $5,284.41 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $2,007.93, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 24, 2024. The award was made without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $4,986.02, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as the...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $13,277.92 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion 30s to the Defense Logistics Agency (DLA), a defense agency. The $3,608.37 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery...
- The federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,851.19 firm-fixed-price delivery order was issued on December 2, 2021, with a completion date of December 3, 2021. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $15,912.49, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 5, 2023. This is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $5,660.95 firm-fixed-price delivery order was awarded to pharmaceutical distributor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,309.33, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,436.29, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This delivery order contract has a firm fixed price pricing type and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...